IFT172 and Alzheimer disease: Encapsulating Slb within macrophage‐derived exosomes (Exo‐Slb) markedly enhanced its binding affinity to Aβ monomers, reduced Aβ aggregation, and modulated astrocyte activation, thus improving cognitive function in AD mouse models [161].